These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 17728712)
1. Mechanisms of disease: angiogenesis and the management of breast cancer. Banerjee S; Dowsett M; Ashworth A; Martin LA Nat Clin Pract Oncol; 2007 Sep; 4(9):536-50. PubMed ID: 17728712 [TBL] [Abstract][Full Text] [Related]
2. Breast tumour angiogenesis. Fox SB; Generali DG; Harris AL Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and bevacitumab in breast cancer. Bando H Breast Cancer; 2007; 14(2):163-73. PubMed ID: 17485901 [TBL] [Abstract][Full Text] [Related]
4. Bevacizumab for advanced breast cancer. Traina TA; Rugo HS; Dickler M Hematol Oncol Clin North Am; 2007 Apr; 21(2):303-19. PubMed ID: 17512451 [TBL] [Abstract][Full Text] [Related]
5. Bevacizumab in the treatment of breast cancer. Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic agents in breast cancer. Salter JT; Miller KD Cancer Invest; 2007 Oct; 25(7):518-26. PubMed ID: 18027149 [No Abstract] [Full Text] [Related]
7. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies. Grothey A; Ellis LM Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis of breast cancer. Schneider BP; Miller KD J Clin Oncol; 2005 Mar; 23(8):1782-90. PubMed ID: 15755986 [No Abstract] [Full Text] [Related]
9. [Angiogenesis targeting in breast cancer]. Fumoleau P; Coudert B; Mayer F; Isambert N; Favier L; Ferrant E Bull Cancer; 2007; 94(7 Suppl):F199-206. PubMed ID: 17964997 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. Roland CL; Dineen SP; Lynn KD; Sullivan LA; Dellinger MT; Sadegh L; Sullivan JP; Shames DS; Brekken RA Mol Cancer Ther; 2009 Jul; 8(7):1761-71. PubMed ID: 19567820 [TBL] [Abstract][Full Text] [Related]
11. Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue? Bozza C; Fontanella C; Buoro V; Mansutti M; Aprile G Expert Rev Clin Pharmacol; 2015 Mar; 8(2):251-65. PubMed ID: 25597501 [TBL] [Abstract][Full Text] [Related]
13. Angiogenesis as a therapeutic target in breast cancer. Koutras AK; Starakis I; Lymperatou D; Kalofonos HP Mini Rev Med Chem; 2012 Oct; 12(12):1230-8. PubMed ID: 22512568 [TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy for breast cancer. Nielsen DL; Andersson M; Andersen JL; Kamby C Breast Cancer Res; 2010; 12(5):209. PubMed ID: 21067536 [TBL] [Abstract][Full Text] [Related]
16. [Advances of VEGF related molecular promoting tumor angiogenesis and targeting therapy]. Guo ZY; Cao BL Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):282-4. PubMed ID: 20654135 [No Abstract] [Full Text] [Related]
17. Tumoral angiogenesis and breast cancer. Khosravi Shahi P; Soria Lovelle A; Pérez Manga G Clin Transl Oncol; 2009 Mar; 11(3):138-42. PubMed ID: 19293050 [TBL] [Abstract][Full Text] [Related]